Author

Raj Nandan Chennuri

Observed institutions: Louisiana State University, Carle Foundation Hospital, Karachi Medical and Dental College, Fatima Jinnah Medical University, Shifa Tameer-e-Millat University, New York Medical College, Louisiana State University in Shreveport, Civil Hospital Karachi, Dow University of Health Sciences, People's University of Medical and Health Sciences for Women, Akhtar Saeed Medical and Dental College

OpenAlex ID: A5068791103

Comparison of Clinical Outcomes Between Culture-Positive and Culture-Negative Sepsis and Septic Shock Patients: A Meta-Analysis

2023 · Muhammad S Afzal, Raj Nandan Chennuri, et al. · Cureus · 29

PDF

Immune Checkpoint Inhibitor–Associated Myocarditis With Multisystem Immune Toxicity in Renal Cell Carcinoma

2026 · Raj Nandan Chennuri, Makarand Madine, et al. · JACC Case Reports · 2

ABCL-080: Atypical Presentation of Diffuse Large B-Cell Lymphoma (DLBCL) As Heart Failure Exacerbation and Refractory Back Pain With Progressive Renal and Respiratory Failure Reflecting Aggressive Nature: A Case Report.

2025 · Raj Nandan Chennuri, P Yendapalli, et al. · Clinical Lymphoma Myeloma & Leukemia · 2

AML-1473: Defining the “Frailty Cliff”: A Restricted Cubic Spline Meta-Analysis of Artificial Intelligence-Derived Continuous Mesenteric Adiposity and Skeletal Muscle Index on Induction Mortality in Acute Myeloid Leukemia

2026 · Faiza Khalid, Haroon Alamy, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: CLL-1494: Continuous Cumulative Exposure to Covalent BTK Inhibitors and the Nonlinear Acceleration of Incident Atrial Fibrillation in Chronic Lymphocytic Leukemia: A Primary Restricted Cubic Spline Meta-Analysis

2026 · Raj Nandan Chennuri, Faiza Khalid, et al. · Clinical Lymphoma Myeloma & Leukemia

CML-1426: When Metabolic Crisis Unmasks Hematologic Malignancy: The Rare Phenomenon of Diabetic Ketoacidosis in Chronic Myeloid Leukemia

2026 · Sandhya Rani Reddy, Raj Nandan Chennuri, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MM-1523: Isolating the Anti-CD38 Component Effect in Newly Diagnosed Multiple Myeloma: A Component-Based Network Meta-Analysis of Phase 3 Randomized Trials

2026 · Raj Nandan Chennuri, Haroon Alamy, et al. · Clinical Lymphoma Myeloma & Leukemia

MM-1498: Solving the Sequencing Labyrinth: A Reinforcement Learning Meta-Analysis of Optimal Treatment Pathways in Triple-Class Refractory Multiple Myeloma

2026 · Haroon Alamy, Raj Nandan Chennuri, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MM-1585: The Calculus of Relapse: A Neural Ordinary Differential Equation Model of Continuous Disease Acceleration Following CAR-T vs Bispecific Therapy in Multiple Myeloma

2026 · Faiza Khalid, Laiba Manzoor, et al. · Clinical Lymphoma Myeloma & Leukemia

AML-1590: The Digital Twin Synthesis: Generating Synthetic Control Arms via Wasserstein Generative Adversarial Networks for Menin Inhibitors in Genetically Defined Acute Myeloid Leukemia

2026 · Raj Nandan Chennuri, Hrishikesh Kommu, et al. · Clinical Lymphoma Myeloma & Leukemia

ABCL-1630: Diffusing the Double-Hit: A Tabular Diffusion Meta-Analysis Generating Counterfactual Survival Trajectories for MYC/BCL2 Double-Hit Lymphoma

2026 · Raj Nandan Chennuri, Faiza Khalid, et al. · Clinical Lymphoma Myeloma & Leukemia

MM-1523: Isolating the Anti-CD38 Component Effect in Newly Diagnosed Multiple Myeloma: A Component-Based Network Meta-Analysis of Phase 3 Randomized Trials

2026 · Raj Nandan Chennuri, Haroon Alamy, et al. · Clinical Lymphoma Myeloma & Leukemia

MM-1585: The Calculus of Relapse: A Neural Ordinary Differential Equation Model of Continuous Disease Acceleration Following CAR-T vs Bispecific Therapy in Multiple Myeloma

2026 · Faiza Khalid, Laiba Manzoor, et al. · Clinical Lymphoma Myeloma & Leukemia

CT-1586: The Goldilocks Zone of Adiposity: A Restricted Cubic Spline Meta-Analysis of Continuous BMI and the Nonlinear Risk of Severe CRS and ICANS in CAR-T Therapy

2026 · Sravani Bhavanam, Haroon Alamy, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: HL-1461: Redefining “Safe” Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

2026 · Haroon Alamy, Raj Nandan Chennuri, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: CT-1586: The Goldilocks Zone of Adiposity: A Restricted Cubic Spline Meta-Analysis of Continuous BMI and the Nonlinear Risk of Severe CRS and ICANS in CAR-T Therapy

2026 · Sravani Bhavanam, Haroon Alamy, et al. · Clinical Lymphoma Myeloma & Leukemia

AML-1601: The Pareto Optimization of Cure: A Primary Bivariate Copula Meta-Analysis Solving the Graftvs-Leukemia Paradox in Acute Myeloid Leukemia

2026 · Faiza Khalid, Laiba Manzoor, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MDS-1556: Serum Ferritin as a Continuous Risk Factor for Major Adverse Cardiovascular Events and Leukemic Transformation in Myelodysplastic Neoplasms: A Restricted Cubic Spline Dose-Response Meta-Analysis and a Methodological Proof-of-Concept Study

2026 · Faiza Khalid, Iman Khan, et al. · Clinical Lymphoma Myeloma & Leukemia

CLL-1494: Continuous Cumulative Exposure to Covalent BTK Inhibitors and the Nonlinear Acceleration of Incident Atrial Fibrillation in Chronic Lymphocytic Leukemia: A Primary Restricted Cubic Spline Meta-Analysis

2026 · Raj Nandan Chennuri, Faiza Khalid, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MM-1451: Clinical Outcomes of PD-1/PD-L1 Inhibitors in Hematologic Malignancies: A Systematic Review Across Lymphoma, Leukemia, and Multiple Myeloma

2026 · Prudhvi Davala, Sandhya Rani Reddy, et al. · Clinical Lymphoma Myeloma & Leukemia

MM-1451: Clinical Outcomes of PD-1/PD-L1 Inhibitors in Hematologic Malignancies: A Systematic Review Across Lymphoma, Leukemia, and Multiple Myeloma

2026 · Prudhvi Davala, Sandhya Rani Reddy, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MM-1520: Redefining the Horizon: A Deep Survival Mixture Meta-Analysis Quantifying the Statistical Cure Fraction of Cellular Therapies in Relapsed Multiple Myeloma

2026 · Haroon Alamy, Raj Nandan Chennuri, et al. · Clinical Lymphoma Myeloma & Leukemia

MM-1441: Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs vs Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis

2026 · Faiza Khalid, Raj Nandan Chennuri, et al. · Clinical Lymphoma Myeloma & Leukemia

HL-1461: Redefining “Safe” Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

2026 · Haroon Alamy, Raj Nandan Chennuri, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MM-1498: Solving the Sequencing Labyrinth: A Reinforcement Learning Meta-Analysis of Optimal Treatment Pathways in Triple-Class Refractory Multiple Myeloma

2026 · Haroon Alamy, Raj Nandan Chennuri, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 41

Citation count: 33

H-index: 2

I10-index: 1